...buying ingredients from China for years, but with their businesses now suffering, even major pharmaceutical companies like AstraZeneca, Bayer, Baxter and Pfizer have announced deals to outsource manufacturing to China. We all know the result: fake heparin...

...the heavyweight pharmaceutical stocks, GlaxoSmithKline gained 4.4 per cent or 49.5p to close at 1,170p while f AstraZeneca rose 5.4 per cent or 133p to reach 2,608p. Neil Parker, a market strategist at Royal Bank of Scotland, said: "It's extremely volatile...

...to a large pharmaceutical company. Jon Symonds, a managing director at Goldman Sachs and former finance director of AstraZeneca, was reported to have said a deal – with a large, unidentified drug developer – to create a new hybrid model of research and development...

...injection), the first antibiotic in a new class of anti-infectives called lipopeptides. Cubist has entered into an agreement with AstraZeneca to handle U.S. hospital sales for their established broad spectrum antibiotic, MERREM I.V.® (meropenem for injection)....

...Health Foundation, who donated $15,000 for $5,000 awards to the top three students. Other major contributors included AstraZeneca, Boehringer Ingelheim, Empire Blue Cross, PepsiCo, Pharmaceutical Research Manufacturers of America, and The City University of...

...The concept and technology has been developed and validated over the last three years by Cellectricon in partnership with AstraZeneca. "We are excited to partner with TAP who are world-renowned for manufacturing industrial quality automation," says Jonas...

...healthy, free of any known risk factors and yet had elevated CRP for no obvious reason." While the press bought AstraZeneca's contrivance that the JUPITER study was so conclusive it was ended early, many of the 470 doctors who posted online comments after...

...group's market position should help it weather the economic woes. Winners: Man Group up 16p at 256p, Sage ahead 10p at 167.8p, AstraZeneca up 133p at 2608p and Eurasian Natural Resources ahead 11.5p at 5055p. Losers: Stagecoach down 28.3p at 143.2p, Rio Tinto...

...a deal to acquire Austrian Airlines AG, giving one of Europe's biggest airlines more routes a... British drugmaker AstraZeneca PLC said Wednesday it named Graham Baker as chief financial officer for North America, effective Jan. 1. Baker, 40, replace... Three...

...a deal to acquire Austrian Airlines AG, giving one of Europe's biggest airlines more routes a... British drugmaker AstraZeneca PLC said Wednesday it named Graham Baker as chief financial officer for North America, effective Jan. 1. Baker, 40, replace... Three...